K63.8211

Clinical Causes: Impaired motility of the small intestine, which allows bacteria to overgrow Structural abnormalities of the gastrointestinal tract, such as strictures or diverticula Certain medical conditions like diabetes, scleroderma, or Crohn's disease that affect gut motility Use of medications that alter gut flora, including antibiotics and proton pump inhibitors Surgical alterations to the gastrointestinal tract, such as resections or bypass surgeries Reduced stomach acid production that normally helps control bacterial growth in the small intestine

Key Symptoms: Bloating and abdominal distension Excessive gas or flatulence Diarrhea or loose stools Steatorrhea (fatty stools) Abdominal pain or discomfort Malnutrition and weight loss in severe cases Nausea or decreased appetite

Diagnosis Path: Diagnosis of hydrogen-subtype SIBO typically involves breath testing, where a patient ingests a sugar solution such as lactulose or glucose. Bacterial overgrowth produces excess hydrogen gas that can be measured in the breath samples taken over time. Elevated hydrogen levels indicate abnormal bacterial proliferation in the small intestine. Additional tests, including blood work and imaging, may be performed to identify underlying causes or related complications.

Treatment Protocols: Management of hydrogen-subtype SIBO often includes a combination of strategies. These may comprise antibiotics targeted at reducing bacterial overgrowth, such as rifaximin, and dietary modifications like a low FODMAP diet to reduce fermentable substrates. Addressing underlying conditions, improving gut motility, and supplementation of nutrients might also be necessary. In some cases, probiotics or other supportive therapies are considered to restore healthy gut flora. Close medical supervision is recommended to monitor progress and prevent recurrence.